2.4.0.8133 - Disclosure - Summary of Significant Accounting Policies (Details 4)truefalsefalse1false falsefalseP01_01_2013To06_30_2013_CustomerAaMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli02false falsefalseP01_01_2012To06_30_2012_CustomerAaMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2012-01-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli03false falsefalseP01_01_2012To12_31_2012_CustomerAaMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2012-01-01T00:00:002012-12-31T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli04false falsefalseP01_01_2011To12_31_2011_CustomerAaMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2011-01-01T00:00:002011-12-31T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli01false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse1false truefalseP01_01_2013To06_30_2013_CustomerAaMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseCustomer A [Member]mslp_CustomerListAxisxbrldihttp://xbrl.org/2006/xbrldimslp_CustomerAaMembermslp_CustomerListAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepurexbrli0nanafalse0Customer A [Member]2false 4mslp_ConcentrationPercentageOfRevenueWithCustomermslp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.310.31falsefalsefalse2truetruefalse0.40.4falsefalsefalse3truetruefalse0.330.33falsefalsefalse4truetruefalse0.410.41falsefalsefalsenum:percentItemTypepureThe concentration percentage of revenue with customer reported during the period.No definition available.false0Concentration percentage of revenue with customers3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false truefalseP01_01_2013To06_30_2013_CustomerBMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseCustomer B [Member]mslp_CustomerListAxisxbrldihttp://xbrl.org/2006/xbrldimslp_CustomerBMembermslp_CustomerListAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepurexbrli0nanafalse0Customer B [Member]4false 4mslp_ConcentrationPercentageOfRevenueWithCustomermslp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.120.12falsefalsefalse2truetruefalse0.110.11falsefalsefalse3truetruefalse0.120.12falsefalsefalse4truetruefalse0.140.14falsefalsefalsenum:percentItemTypepureThe concentration percentage of revenue with customer reported during the period.No definition available.false0Concentration percentage of revenue with customers5false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false truefalseP01_01_2013To06_30_2013_CustomerCMembermslpCustomerListAxishttp://www.sec.gov/CIK0001415684duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseCustomer C [Member]mslp_CustomerListAxisxbrldihttp://xbrl.org/2006/xbrldimslp_CustomerCMembermslp_CustomerListAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepurexbrli0nanafalse0Customer C [Member]6false 4mslp_ConcentrationPercentageOfRevenueWithCustomermslp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.060.06falsefalsefalse2truetruefalse0.170.17falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsenum:percentItemTypepureThe concentration percentage of revenue with customer reported during the period.No definition available.false0Concentration percentage of revenue with customersfalseSummary of Significant Accounting Policies (Details 4)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.musclepharm.com/role/SummaryOfSignificantAccountingPoliciesDetails446